share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Apr 30 08:06

Gainers

  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. The company's market cap stands at $2.6 million.
  • GeneDx Hldgs (NASDAQ:WGS) shares rose 43.54% to $15.79. The company's market cap stands at $411.3 million. As per the news, the Q1 earnings report came out yesterday.
  • BioRestorative Therapies (NASDAQ:BRTX) shares moved upwards by 16.93% to $1.45. The company's market cap stands at $9.8 million.
  • Vaccinex (NASDAQ:VCNX) shares moved upwards by 15.72% to $6.77. The company's market cap stands at $10.7 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock moved upwards by 14.19% to $8.61. The market value of their outstanding shares is at $9.2 million.
  • Tenet Healthcare (NYSE:THC) stock increased by 9.93% to $109.0. The company's market cap stands at $10.8 billion. The company's, Q1 earnings came out today.

Losers

  • SHL Telemedicine (NASDAQ:SHLT) stock decreased by 10.0% to $5.0 during Tuesday's pre-market session. The company's market cap stands at $81.9 million.
  • Nektar Therapeutics (NASDAQ:NKTR) stock declined by 8.87% to $1.33. The market value of their outstanding shares is at $244.3 million.
  • GlucoTrack (NASDAQ:GCTK) shares fell 8.17% to $0.51. The market value of their outstanding shares is at $13.7 million.
  • GE HealthCare Techs (NASDAQ:GEHC) shares declined by 7.81% to $82.0. The market value of their outstanding shares is at $37.4 billion. As per the news, the Q1 earnings report came out today.
  • Virios Therapeutics (NASDAQ:VIRI) stock fell 7.28% to $0.44. The market value of their outstanding shares is at $8.3 million.
  • 180 Life Sciences (NASDAQ:ATNF) shares decreased by 7.15% to $1.82. The market value of their outstanding shares is at $1.5 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment